Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NuGen Medical Devices specializes in developing and commercializing needle-free drug delivery devices, primarily for subcutaneous administration of therapeutics, including insulin and semaglutide. Their platform, InsuJet, delivers medications as a fine jet stream—administered in under one-tenth of a second—resulting in virtually painless, mark-free administration. Clinical studies have demonstrated over 40% faster insulin uptake compared to traditional needle injections. The technology is commercially available in over 40 countries, with regulatory approvals including Health Canada and Europe[1][2][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NuGen Medical Devices.